Cambrex Karlskoga AB
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Sweden
- Registered address
- Bjorkborns Industriomrade, Karlskoga, - 69185, Sweden (SWE)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3001686607 · DUNS 353954043
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-05-24
- VAIDrug Quality Assurance2019-04-04
- VAIDrug Quality Assurance2016-05-27
- VAIDrug Quality Assurance2014-03-21
- VAIDrug Quality Assurance2011-02-03
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- BUPIVACAINE and MELOXICAMHeron Therapeutics, Inc.
- remimazolam besylateAcacia Pharma, Ltd.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.